-
EP2760468
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2760468
| EP2760468 - CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.06.2018 Database last updated on 15.06.2024 | |
| Former | Examination is in progress Status updated on 08.09.2017 | Most recent event Tooltip | 01.06.2018 | Application deemed to be withdrawn | published on 04.07.2018 [2018/27] | Applicant(s) | For all designated states The University of British Columbia 103 - 6190 Agronomy Road Vancouver, BC V6T 1Z3 / CA | [2014/32] | Inventor(s) | 01 /
BRUNHAM, Robert C. 64 McKenzie Crescent Sidney, British Columbia V8L 5Y7 / CA | 02 /
FOSTER, Leonard James 4791 Lancelot Drive Richmond, British Columbia V7C 4S4 / CA | [2014/32] | Representative(s) | Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB | [N/P] |
| Former [2014/32] | Atkinson, Jennifer Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB | Application number, filing date | 12836110.2 | 01.10.2012 | WO2012CA50691 | Priority number, date | US201161541944P | 30.09.2011 Original published format: US 201161541944 P | [2014/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013044398 | Date: | 04.04.2013 | Language: | EN | [2013/14] | Type: | A1 Application with search report | No.: | EP2760468 | Date: | 06.08.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.04.2013 takes the place of the publication of the European patent application. | [2014/32] | Search report(s) | International search report - published on: | CA | 04.04.2013 | (Supplementary) European search report - dispatched on: | EP | 14.07.2015 | Classification | IPC: | A61K39/118, A61P31/04, A61P37/04, G01N33/569, A61K39/00 | [2015/18] | CPC: |
A61K39/118 (EP,KR,US);
A61K38/08 (KR);
A61K38/10 (KR);
A61P31/04 (EP);
A61P37/04 (EP,KR);
G01N33/56927 (KR,US);
A61K2039/55572 (EP,KR,US)
(-)
|
| Former IPC [2014/32] | A61K39/118, A61P31/04, A61P37/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/32] | Title | German: | CHLAMYDIEN- ANTIGENZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | [2014/32] | English: | CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF | [2014/32] | French: | COMPOSITIONS D'ANTIGÈNE DE CHLAMYDIA ET LEURS UTILISATIONS | [2014/32] | Entry into regional phase | 15.04.2014 | National basic fee paid | 15.04.2014 | Search fee paid | 15.04.2014 | Designation fee(s) paid | 15.04.2014 | Examination fee paid | Examination procedure | 15.04.2014 | Examination requested [2014/32] | 08.02.2016 | Amendment by applicant (claims and/or description) | 11.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 23.01.2018 | Application deemed to be withdrawn, date of legal effect [2018/27] | 21.02.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.09.2017 | Fees paid | Renewal fee | 03.09.2014 | Renewal fee patent year 03 | 27.10.2015 | Renewal fee patent year 04 | 28.10.2016 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.10.2017 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2008156729 (EMERGENT PRODUCT DEV GAITHERSB [US], et al) [X] 1,2,6,8 * sequence 13 * * paragraph [0001] * * paragraph [0021] - paragraph [0029] * [I] 3,4,7,9-15; | [Y]WO2010085896 (BRITISH COLUMBIA CANCER AGENCY [CA], et al) [Y] 3-5,7,9-15 * paragraph [0175] - paragraph [0177]; figure 1; examples 1-14; table 2 *; | [E]WO2014022936 (UNIV BRITISH COLUMBIA [CA]) [E] 1,2,5-8 * paragraph [0010] - paragraph [0012]; sequence 62 *; | [Y] - H. YU ET AL, "Chlamydia muridarum T-Cell Antigens Formulated with the Adjuvant DDA/TDB Induce Immunity against Infection That Correlates with a High Frequency of Gamma Interferon (IFN- )/Tumor Necrosis Factor Alpha and IFN- /Interleukin-17 Double-Positive CD4+ T Cells", INFECTION AND IMMUNITY, (20100315), vol. 78, no. 5, doi:10.1128/IAI.01374-09, ISSN 0019-9567, pages 2272 - 2282, XP055148827 [Y] 3-5,7,9-15 * abstract * DOI: http://dx.doi.org/10.1128/IAI.01374-09 | [Y] - KARUNAKARAN K P ET AL, "Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (20080215), vol. 180, no. 4, ISSN 0022-1767, pages 2459 - 2465, XP002694535 [Y] 5 * figure 2; table 1 * DOI: http://dx.doi.org/10.4049/jimmunol.180.4.2459 | [IP] - H. YU ET AL, "Chlamydia muridarum T Cell Antigens and Adjuvants That Induce Protective Immunity in Mice", INFECTION AND IMMUNITY, (20120401), vol. 80, no. 4, doi:10.1128/IAI.06338-11, ISSN 0019-9567, pages 1510 - 1518, XP055177070 [IP] 1-15 * table 1 * DOI: http://dx.doi.org/10.1128/IAI.06338-11 | [A] - "RecName: Full=Probable outer membrane protein PmpH; AltName: Full=Polymorphic membrane protein H; Flags: Precursor;", UniProt, (20010601), Database accession no. Q9PL44, URL: EBI, XP002737645 [A] 1-15 * sequence . * | [ ] - READ T D ET AL, "Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, (20000315), vol. 28, no. 6, doi:10.1093/NAR/28.6.1397, ISSN 0305-1048, pages 1397 - 1406, XP002164566 DOI: http://dx.doi.org/10.1093/nar/28.6.1397 | [A] - KARUNA P. KARUNAKARAN ET AL, "Development of a Chlamydia trachomatis T cell Vaccine", HUMAN VACCINES, (20100801), vol. 6, no. 8, doi:10.4161/hv.6.8.12299, ISSN 1554-8600, pages 676 - 680, XP055148823 [A] 1-15 DOI: http://dx.doi.org/10.4161/hv.6.8.12299 | [T] - KARUNA P. KARUNAKARAN ET AL, "Outer membrane proteins preferentially load MHC class II peptides: Implications for a Chlamydia trachomatis T cell vaccine", VACCINE, (20150401), vol. 33, no. 18, doi:10.1016/j.vaccine.2015.02.055, ISSN 0264-410X, pages 2159 - 2166, XP055197856 [T] 1-15 DOI: http://dx.doi.org/10.1016/j.vaccine.2015.02.055 | [T] - YU HONG ET AL, "Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine againstChlamydia muridarumgenital infection in three strains of mice", VACCINE, (20140630), vol. 32, no. 36, doi:10.1016/J.VACCINE.2014.06.002, ISSN 0264-410X, pages 4672 - 4680, XP029039163 [T] 1-15 DOI: http://dx.doi.org/10.1016/j.vaccine.2014.06.002 | International search | [X]EP2218730 (MERCK SERONO BIODEVELOPMENT [FR]); | [X]WO2006104890 (GLAXOSMITHKLINE BIOLOG SA [BE], et al); | [X]WO2010100632 (NOVARTIS AG [CH], et al); | [Y] - KARUNAKARAN ET AL., "`Development of a Chlamydia trachomatis T-cell vaccine", HUMAN VACCINES, (201008), vol. 6, pages 676 - 680, XP055148823 DOI: http://dx.doi.org/10.4161/hv.6.8.12299 | [Y] - YU ET AL., "`Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: Correlation with MHC Class II peptide presentation and multifunctional Th1 cells", THE JOURNAL OF IMMUNOLOGY, (20110315), vol. 186, pages 3615 - 3621, XP055148825 DOI: http://dx.doi.org/10.4049/jimmunol.1002952 | [Y] - YU ET AL., "`Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-y)/tumor necrosis factor alpha and IFN- y/Interleuhin-17 double-positive CD4+ T cells", INFECTION AND IMMUNITY, (201005), vol. 78, pages 2272 - 2282, XP055148827 DOI: http://dx.doi.org/10.1128/IAI.01374-09 |